BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Career Advice

  10 Resume Mistakes to Avoid at All Costs

  Crafting a well-organized, powerful resume is important to leave a great impact on recruiters. But all your hard work can go in vain if you make these resume mistakes.

  February 6, 2019

   · 

  3 min read

   · 

  Editorial Staff
• Job Trends

  MagForce AG: Newly launched ’NanoTherm® Therapy School’ kicks off with successful first training session

  MagForce introduces practice-oriented, unique, multifaceted application training for the use of NanoTherm Therapy in treating brain tumors

  February 6, 2019

   · 

  4 min read
• 

  Business

  Dr. Peter Kaspar Joins First Light Diagnostics Board of Directors

  First Light Diagnostics announced the addition of Dr. Peter Kaspar to the company’s board of directors effective January 1, 2019.

  February 6, 2019

   · 

  2 min read
• 

  Business

  GENFIT: Reports Full-Year 2018 Financial Results: cash position of €207.2m as of 12.31.2018

  Cash position of €207.2 million as of December 31, 2018, compared to €273.8 million as of December 31, 2017

  February 6, 2019

   · 

  5 min read
• Business

  Suven Revenue up by 40.24%; PAT up by 40.27% for quarter ended December’ 2018

  Suven Life Sciences Limited announced its Un-audited financial results for the quarter ended 31st December 2018.

  February 6, 2019

   · 

  2 min read
• Microbix Provides Quality Assessment Products Update

  New Customers, More Products, and Expanding Capacity

  February 6, 2019

   · 

  5 min read
• 

  Business

  Gladstone Institutes’ Robert Mahley Launches Alzheimer’s Biotech GABAeron

  Robert Mahley, founder and president of Gladstone Institutes, an internationally-recognized expert on heart disease, cholesterol metabolism and Alzheimer’s disease, is launching a biotech company to focus on Alzheimer’s disease. The company is called GABAeron.

  February 6, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  MacroGenics Soars on Phase III Breast Cancer Study

  Shares of Rockville, Md.-based MacroGenics, Inc. have skyrocketed nearly 160 percent in premarket trading after the company announced its Phase III HER2-positive metastatic breast cancer study hit the mark.

  February 6, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Eli Lilly’s Lartruvo Failure Puts a Crimp in Its Plans for the Oncology Market

  Like many other big pharma companies, Eli Lilly & Co. reported a good 2018 with a less optimistic view of 2019. Fourth-quarter 2018 revenue grew by 5 percent, driven by newer drugs. Operating expenses also went up by a percentage point. Full-year 2018 revenue grew by 7 percent to $24.556 billion.

  February 6, 2019

   · 

  3 min read

   · 

  Mark Terry
• Business

  GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message

  Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development

  February 6, 2019

   · 

  4 min read